FR2834897B1 - Composition pharmaceutique orodispersible de testosterone - Google Patents

Composition pharmaceutique orodispersible de testosterone

Info

Publication number
FR2834897B1
FR2834897B1 FR0200795A FR0200795A FR2834897B1 FR 2834897 B1 FR2834897 B1 FR 2834897B1 FR 0200795 A FR0200795 A FR 0200795A FR 0200795 A FR0200795 A FR 0200795A FR 2834897 B1 FR2834897 B1 FR 2834897B1
Authority
FR
France
Prior art keywords
testosterone
pharmaceutical composition
orodispersible pharmaceutical
orodispersible
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0200795A
Other languages
English (en)
Other versions
FR2834897A1 (fr
Inventor
Patrick Wuthrich
Herve Rolland
Marc Julien
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Servier SAS
Original Assignee
Laboratoires Servier SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Servier SAS filed Critical Laboratoires Servier SAS
Priority to FR0200795A priority Critical patent/FR2834897B1/fr
Priority to ARP030100180A priority patent/AR038209A1/es
Priority to PCT/FR2003/000195 priority patent/WO2003061664A1/fr
Publication of FR2834897A1 publication Critical patent/FR2834897A1/fr
Application granted granted Critical
Publication of FR2834897B1 publication Critical patent/FR2834897B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
FR0200795A 2002-01-23 2002-01-23 Composition pharmaceutique orodispersible de testosterone Expired - Fee Related FR2834897B1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR0200795A FR2834897B1 (fr) 2002-01-23 2002-01-23 Composition pharmaceutique orodispersible de testosterone
ARP030100180A AR038209A1 (es) 2002-01-23 2003-01-22 Composicion farmaceutica dispersable oralmente de testosterona
PCT/FR2003/000195 WO2003061664A1 (fr) 2002-01-23 2003-01-22 Composition pharmaceutique orodisfersible de testosterone

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0200795A FR2834897B1 (fr) 2002-01-23 2002-01-23 Composition pharmaceutique orodispersible de testosterone

Publications (2)

Publication Number Publication Date
FR2834897A1 FR2834897A1 (fr) 2003-07-25
FR2834897B1 true FR2834897B1 (fr) 2004-02-27

Family

ID=27589559

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0200795A Expired - Fee Related FR2834897B1 (fr) 2002-01-23 2002-01-23 Composition pharmaceutique orodispersible de testosterone

Country Status (3)

Country Link
AR (1) AR038209A1 (fr)
FR (1) FR2834897B1 (fr)
WO (1) WO2003061664A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2898729C (fr) * 2012-11-14 2018-05-08 Abon Pharmaceuticals, Llc Systeme d'administration d'un medicament par voie orale transmuqueuse

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL189235C (nl) * 1974-02-28 1993-02-16 Akzo Nv Werkwijze voor de bereiding van een oraal toe te dienen farmaceutisch preparaat met androgene werking.
DE3506276C1 (de) * 1985-02-22 1986-04-24 Meggle Milchindustrie Gmbh & Co Kg, 8094 Reitmehring Direkttablettiermittel
CA2179382C (fr) * 1994-01-31 2009-11-10 Takao Mizumoto Produits moules comprimes se dissolvant dans la bouche et procede de fabrication
GB9700878D0 (en) * 1997-01-17 1997-03-05 Scherer Ltd R P Dosage forms and method for ameliorating male erectile dysfunction
ATE371439T1 (de) * 2000-07-27 2007-09-15 Roquette Freres Granulat bestehend aus stärke und laktose

Also Published As

Publication number Publication date
FR2834897A1 (fr) 2003-07-25
AR038209A1 (es) 2005-01-05
WO2003061664A1 (fr) 2003-07-31

Similar Documents

Publication Publication Date Title
FI20011478A (fi) Farmaseuttinen koostumus
NO20033384L (no) Farmasoytisk formulering
PT1467724E (pt) Composicao farmaceutica orodispersavel de agomelatina
IS6986A (is) Lyfjasamsetning í vökvaformi
DK1425019T3 (da) Farmaceutisk sammensætning omfattende et androgen
NO20033785D0 (no) Farmasöytisk formulering
DK1458377T3 (da) Farmaceutiske sammensætninger indeholdende tegaserod
IS7051A (is) Lyfjasamsetningar
NO20035627D0 (no) Farmasöytisk formulering
PT1558263E (pt) Composicao farmaceutica de libertacao prolongada
FI20022128A (fi) Farmaseuttinen koostumus
FR2834893B1 (fr) Composition pharmaceutique orodispersible de perindopril
FR2834896B1 (fr) Composition pharmaceutique orodispersible d'ivabradine
ITMI20021684A1 (it) Composizione farmaceutica di peptide nasale
EE200300468A (et) Pravastatiini stabiilne farmatseutiline kompositsioon
FR2834897B1 (fr) Composition pharmaceutique orodispersible de testosterone
NO20033073D0 (no) Farmasöytisk sammensetning inneholdende citalopram
FR2834894B1 (fr) Composition pharmaceutique orodispersible de piribedil
FR2834892B1 (fr) Composition pharmaceutique orodispersible de mitiglinide
NO20044164L (no) Farmasoytiske sammensetninger
NO20041236L (no) Farmasoytisk formulering
DOP2002000508A (es) Composición farmaceutica
FI5468U1 (fi) Farmaseuttinen koostumus
ITMI20020926A0 (it) Composizioni farmaceutiche riepitelizzanti
SE0100847D0 (sv) Novel pharmaceutical composition

Legal Events

Date Code Title Description
ST Notification of lapse